Duolingo just crossed $1 billion in revenue and delivered a 367% surge in net earnings — yet the stock trades at a trailing P/E of just 11x. For a market-leading EdTech platform with 50 million daily active users, that’s a number you’d normally associate with a slow-moving industrial company, not one of the most recognisable consumer brands on the planet.Read more

Novo Nordisk’s shares slump after lowered outlook and louder competition headlines, but the business still leads a growing diabetes and weight-loss market with new treatments on the way. The key question is whether today’s worries around pricing pressure, copycat drugs, and a heavy reliance on one blockbuster are truly lasting—or just masking a stronger long-term story.Read more